普鲁卡洛普里德对一个医学复杂的青少年的精神病学副作用
Clare Hawkes1, Jonathan J Chandran2, Kasia Kozlowska3,4,5
1School of Psychological Sciences, University of Tasmania, Launceston, Australia.
Case reports in pediatrics
|April 9, 2025
概括
用于慢性便秘的普鲁卡洛普里德可能会导致严重的神经精神疾病副作用,如幻觉和自杀念头. 医疗保健提供者应监测患者,特别是那些有先前精神健康状况的患者.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 普鲁卡洛普里德是一种选择性5-HT4受体激动剂,用于慢性便秘.
- 当药不足时,它被处方.
- 这个案子涉及一个15岁的女性,她有复杂的健康问题.
研究的目的:
- 在普鲁卡洛普里德 (prucalopride) 给药后报告出现不良神经精神症状的情况.
- 突出脆弱患者群体的潜在风险.
主要方法:
- 一个15岁的女性患有自身免疫性肠道神经病变的案例研究.
- 使用一次2mg剂量的普鲁卡洛普里德.
- 对不良事件的观察和随后的管理.
主要成果:
- 患者经历视觉和听觉幻觉和自杀想法后prucalopride.
- 在停止服用普鲁卡洛普里德并开始精神病学干预后,症状得到缓解.
结论:
- 这是普鲁卡洛普里德对神经精神病的影响的第二个报告.
- 临床医生必须考虑这些风险,特别是在具有并发性神经发育或精神病史的患者中.
- 建议加强对这些患者的监测.
相关概念视频
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
190
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
190
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
52
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
52
Drugs for Treatment of Constipation-Predominant IBS
117
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
117
Drugs for Treatment of Diarrhea-Predominant IBS
126
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
126
Psychosis and Antipsychotic Drugs: Overview
157
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
157
Psychosis: Goals of Pharmacotherapy
97
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
97


